The Psoriasis Echo Study
Study Purpose
In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.
Recruitment Criteria
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms |
No |
Study Type
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies. |
Observational |
Eligible Ages | 18 Years and Over |
Gender | All |
Trial Details
Trial ID:
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries. |
NCT04950218 |
Phase
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use. |
|
Lead Sponsor
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data. |
Herlev and Gentofte Hospital |
Principal Investigator
The person who is responsible for the scientific and technical direction of the entire clinical study. |
Tor Biering-Sørensen, MD, PhD, MPHClaus Zachariae, MD, DMScLone Skov, MD, PhD, DMScGunnar Gislason, MD, PhD |
Principal Investigator Affiliation | Department of Cardiology, Herlev and Gentofte University Hospital, University of CopenhagenDepartment of Dermato-Allergology, Herlev and Gentofte University Hospital, University of CopenhagenDepartment of Dermato-Allergology, Herlev and Gentofte University Hospital, University of CopenhagenDepartment of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen |
Agency Class
Category of organization(s) involved as sponsor (and collaborator) supporting the trial. |
Other |
Overall Status | Recruiting |
Countries | Denmark |
Conditions
The disease, disorder, syndrome, illness, or injury that is being studied. |
Psoriasis, Cardiovascular Diseases, Cardiovascular Risk Factor, Cardiovascular Pathology, Psoriasis Vulgaris, Psoriatic Nail, Psoriasis Face, Psoriasis Guttate, Psoriasis Gyrata, Psoriasis Diffusa, Psoriasis Palmaris, Psoriasis Annularis, Psoriasis Circinata, Psoriasis Plantaris, Psoriasis Universalis, Psoriasis Geographica, Left Ventricular Dysfunction, Myocardial Infarction, Myocardial Ischemia, Heart Failure, Stroke, Heart Diseases, Heart Failure, Systolic, Heart Failure, Diastolic |
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.